Evidence map›Paper›PMID 39525003›Full record

ArticleTranslational cancer research2024

Prognostic value and anti-tumor immunity role of

Haodi Wang, Yue Wang, Pengyu Tan, Yichi Liu, Sa Zhou, Wenjian Ma

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Translational cancer research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Bioinformatic Approach to Identify Positive PrognosticInternational journal of molecular sciences · 2025
    Article
  3. Prognostic significance ofTranslational cancer research · 2025
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Haodi Wang *College of Biotechnology, Tianjin University of Science and Technology, Tianjin, China.
Yue Wang *College of Future Education, Beijing Normal University at Zhuhai, Zhuhai, China.
Pengyu TanCollege of Biotechnology, Tianjin University of Science and Technology, Tianjin, China.
Yichi LiuCollege of Biotechnology, Tianjin University of Science and Technology, Tianjin, China.
Sa ZhouCollege of Biotechnology, Tianjin University of Science and Technology, Tianjin, China.
Wenjian MaCollege of Biotechnology, Tianjin University of Science and Technology, Tianjin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Transmembrane p24 trafficking protein 9 ( Methods: We utilized R language along with The Cancer Genome Atlas (TCGA), UCSC Xena (University of California, Santa Cruz Xena Browser), Human Protein Atlas (HPA), and other datasets to investigate Results: Conclusions:

Indexed as

cancer immunitypan-cancer analysisprognosis biomarkerTransmembrane p24 trafficking protein 9 (TMED9)tumor microenvironment (TME)

Identifiers

PMID39525003
PMCPMC11543038

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.